Immunic Therapeutics
Dr. Andreas Muehler is the CMO at Immunic Therapeutics. Prior to joining Immunic, they served as the interim product manager for gastroenterology and IBD products at Ferring Pharmaceuticals, and as the interim medical director at Alimera Sciences. Dr. has also held positions at Millennium Pharmaceuticals and Takeda Pharmaceuticals.
Dr. Andreas Muehler has an MBA from Duke University - The Fuqua School of Business and an MD from Humboldt-Universität zu Berlin.
This person is not in any offices
Immunic Therapeutics
1 followers
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies